AI Signal & Stock Analysis · Avoid ↓
As of Aug 14 2026, 1:04 PM, AkshayaAI's signal for AXSM is Avoid ↓; the stock is at $215.05 (+0.64% today); neutral (RSI 41); technical trend is down-trend; news sentiment is nan.
Data as of Aug 14 2026, 1:04 PM. Informational analytics only — not investment advice.
| AI signal (Strength) | Avoid ↓ |
|---|---|
| Price | $215.05 |
| Change today | +0.64% |
| RSI (14) | 41.45 |
| Relative volume | 0.34 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | $11.3B |
| Forward P/E | 45.60 |
| 52-week high | -17.4% away |
| 52-week low | +99.3% above |
| Technical trend | Down-trend (since 2024-01-26) |
| News sentiment | Nan |
| Sector | Healthcare-Genetherapy |
| Next earnings | 8/10/2026 8:30:00 AM |
As of Aug 14 2026, 1:04 PM, AkshayaAI assigns AXSM (Axsome Therapeutics Inc) a Avoid signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.
AXSM's RSI is neutral (RSI 41). A reading above 70 is typically considered overbought and below 30 oversold.
AXSM is trading about 17% below its 52-week high and 99% above its 52-week low as of Aug 14 2026, 1:04 PM.
AXSM's next earnings date is 8/10/2026 8:30:00 AM.
AXSM is classified under Healthcare-Genetherapy in AkshayaAI's taxonomy.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 1:04 PM and may not reflect real-time prices. Always do your own research.
Instant, data-backed answers — free to try.